Back
CytomX Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
38
CTMX
CytomX Therapeutics
Last Price:
$2.13
Seasonality Move:
-1.04%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bearish and CTMX is experiencing selling pressure, which indicates risk of future bearish movement.
CytomX Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.61 | Sell |
| 20-day SMA: | 2.48 | Sell |
| 50-day SMA: | 1.63 | Buy |
| 200-day SMA: | 1.13 | Buy |
| 8-day EMA: | 2.49 | Sell |
| 20-day EMA: | 2.38 | Sell |
| 50-day EMA: | 1.81 | Buy |
| 200-day EMA: | 0.73 | Buy |
CytomX Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 46.55 | Sell |
| Chaikin Money Flow: | -3214388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 2.69) | Sell |
| Bollinger Bands (100): | (0.4 - 1.94) | Buy |
CytomX Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 2.11 while CTMX 8-day simple moving average is 2.61, which is a Sell signal.
-
The stock price of CTMX is 2.11 while CytomX Therapeutics 20-day SMA is 2.48, which makes it a Sell.
-
CytomX Therapeutics 50-day simple moving average is 1.63 while CTMX share price is 2.11, making it a Buy technically.
-
CTMX stock price is 2.11 and CytomX Therapeutics 200-day simple moving average is 1.13, creating a Buy signal.
CTMX Technical Analysis vs Fundamental Analysis
Sell
38
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a SellThe current CytomX Therapeutics [CTMX] share price is $2.11. The Score for CTMX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
332.4M
Price in USD:
2.11
Share Volume:
4.1M
CytomX Therapeutics 52-Week Range
52-Week High:
3.10
52-Week Low:
0.40
Sell
38
CytomX Therapeutics (CTMX)
is a Sell
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?The CytomX Therapeutics stock price is 2.11 USD today.
-
Will CTMX stock go up or go down?CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is CytomX Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is overvalued.
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 2.11 while CTMX 8-day exponential moving average is 2.49, which is a Sell signal.
-
The stock price of CTMX is 2.11 while CytomX Therapeutics 20-day EMA is 2.38, which makes it a Sell.
-
CytomX Therapeutics 50-day exponential moving average is 1.81 while CTMX share price is 2.11, making it a Buy technically.
-
CTMX stock price is 2.11 and CytomX Therapeutics 200-day simple moving average is 0.73, creating a Buy signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.32 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
-
CTMX Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting CytomX Therapeutics is a Buy
-
CytomX Therapeutics Relative Strength Index (RSI) is 46.55, which suggest CytomX Therapeutics is oversold
-
The Bollinger Bands (25) for CytomX Therapeutics is (2.13 - 2.69), which suggest CytomX Therapeutics is a Buy
-
The Bollinger Bands (100) for CytomX Therapeutics is (0.4 - 1.94), which suggest CytomX Therapeutics is a Buy
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.